Orchard Therapeutics PLC (NASDAQ:ORTX)
| 0.4551 Delayed Data As of May 13 |  +0.0516 / +12.21%Today’s Change | 0.41 Today|||52-Week Range 5.75 | -65.52% Year-to-Date |
Latest ORTX News | Press Releases
No recent news for Orchard Therapeutics PLC.
Today’s Trading
| Previous close | 0.42 |
| Today’s open | 0.43 |
| Day’s range | 0.42 - 0.48 |
| Volume | 1,156,920 |
| Average volume (3 months) | 603,651 |
| Market cap | $57.3M |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | +24.28% |
| Earnings growth (this year) | +18.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -35.96% |
| P/E ratio | NM |
| Price/Sales | 97.70 |
| Price/Book | 0.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Herantis Pharma Oyj | 0.00 | 0.00% |
| MDWDMediwound Ltd | -0.03 | -1.57% |
| ADMPAdamis Pharmaceutica... | +0.03 | +9.91% |
| ENTXEntera Bio Ltd | +0.06 | +2.87% |
Data as of 4:00pm ET, 05/13/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $1.7M |
| Annual profit (last year) | -$144.6M |
| Net profit margin | -8,631.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
